Namely, the nuclear retention of pSMAD3L S213 is reported to enhance pro-oncogenic signaling in cancer cells, by facilitating mitogenic signaling via the upregulation of the transcription factor c-Myc [64,70,75,76,77,82]. This evidence concerns the gene MYC and cancer.